Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
CUV Announcements
CLINUVEL update on Level II ADR…
CUV
CLINUVEL PHARMACEUTICALS LIMITED
Market sensitive
CLINUVEL update on Level II ADR upgrade, Nasdaq uplist
Date and time
28 April 2026 at 6:50 pm
Announcement type
Company Administration
Show details
Hide details
Category
Other
Report codes
12008
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
CUV announcement history
Recent CUV announcements
CLINUVEL Annual Results - Investor Webinar
Becoming a substantial holder
CLINUVEL's injectable peptide platform
Commercial update on vitiligo
Update - SCENESSE in vitiligo
Notification of cessation of securities - CUV